摘要 |
The disclosure concerns indolin-2-one pyridine compounds of general formula (I): wherein R<SUB>0</SUB>, R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, Z and B have the meanings given in the description, and pharmaceutically acceptable salts thereof; and also pharmaceutical compositions comprising, processes for making and methods of using said compounds.
|